文献速递脑血管病神经重症与神经感染

低血红蛋白导致血肿扩大和脑出血预后不良

Low Hemoglobin Causes Hematoma Expansion and Poor Intracerebral Hemorrhage Outcomes.
PubMed 文献 · Stroke · 2025-03-20

多中心前瞻性观察队列纳入2997例脑出血患者,分析1190例,发现基线血红蛋白每降低1 g/dL,血肿扩大和3个月不良预后的调整比值比分别为1.10和1.11。贫血小鼠模型显示血肿扩大、24小时病变体积和死亡率均高于非贫血小鼠。

要点

  • 基线血红蛋白每降低1 g/dL,血肿扩大风险调整OR为1.10(95%CI 1.02-1.19)。
  • 基线血红蛋白每降低1 g/dL,3个月不良预后调整OR为1.11(95%CI 1.03-1.21)。
  • 贫血小鼠较非贫血小鼠血肿扩大更显著、24小时病变体积更大、死亡率更高。

核心结论

  • 在人类队列和小鼠模型中,贫血可能对血肿扩大和脑出血不良预后起因果作用。
  • 需要额外研究来明确纠正贫血能否改善这些结局。

研究设计与样本

  • 多中心前瞻性观察队列研究,2010年至2016年纳入2997例脑出血患者,分析其中1190例有基线血红蛋白测量和系列CT神经影像的患者,排除有全身性凝血功能障碍证据者。
  • 使用贫血与非贫血C57/BL6小鼠的胶原酶脑出血模型进行系列神经影像评估。

主要发现

  • 分析1190例患者,平均年龄61岁,62%为男性。
  • 基线血红蛋白较低与血肿扩大风险增加相关(每降低1 g/dL的调整OR 1.10,95%CI 1.02-1.19)。
  • 基线血红蛋白较低与3个月不良临床预后相关(每降低1 g/dL的调整OR 1.11,95%CI 1.03-1.21)。
  • 6个月和12个月不良预后也观察到类似关系。
  • 在动物模型中,贫血小鼠较非贫血小鼠血肿扩大更显著、24小时病变体积更大、死亡率更高。

关键数值与推荐

  • 血肿扩大定义为体积增长≥33%和/或≥6 mL。
  • 不良长期神经功能预后定义为改良Rankin量表评分4-6分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要额外研究来明确纠正贫血能否改善这些结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although lower hemoglobin levels associate with worse intracerebral hemorrhage (ICH) outcomes, causal drivers for this relationship remain unclear. We investigated the hypothesis that lower hemoglobin relates to increased hematoma expansion risk and poor outcomes using human observational data and assessed causal relationships using a translational murine model of anemia and ICH. METHODS: A multicenter, prospective observational cohort study of 2997 patients with ICH enrolled between 2010 and 2016 was assessed. Patients with baseline hemoglobin measurements and serial computed tomography neuroimaging were included for analyses. Patients with systemic evidence of coagulopathy were excluded. Separate regression models assessed relationships of baseline hemoglobin with hematoma expansion (≥33% and/or ≥6 mL growth) and poor long-term neurological outcomes (modified Rankin Scale score of 4-6) after adjusting for relevant covariates. Using a murine collagenase ICH model with serial neuroimaging in anemic versus nonanemic C57/BL6 mice, intergroup differences in ICH lesion volume, lesion volume changes, and early mortality were assessed. RESULTS: Among 1190 ICH patients analyzed, the mean age was 61 years old, and 62% of the cohort were males. Lower baseline hemoglobin levels are associated with increased odds of hematoma expansion (adjusted odds ratio per -1 g/dL hemoglobin decrement, 1.10 [95% CI, 1.02-1.19]) and poor 3-month clinical outcomes (adjusted odds ratio per -1 g/dL hemoglobin decrement, 1.11 [95% CI, 1.03-1.21]). Similar relationships were seen with poor 6- and 12-month outcomes. In our animal model, anemic mice had significantly greater ICH lesion expansion, 24-hour lesion volumes, and greater mortality, as compared with nonanemic mice. CONCLUSIONS: These results, in a human cohort and a mouse model, provide novel evidence suggesting that anemia has causal roles in hematoma expansion and poor ICH outcomes. Additional studies are required to clarify whether correcting anemia can improve these outcomes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Cottarelli A, Mamoon R, Ji R, et al. Low Hemoglobin Causes Hematoma Expansion and Poor Intracerebral Hemorrhage Outcomes. Stroke. 2025. PMID: 40110594. doi:10.1161/STROKEAHA.124.049499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。